nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—saliva—conduct disorder	0.123	0.395	CbGeAlD
Octreotide—SSTR4—brain—conduct disorder	0.0588	0.188	CbGeAlD
Octreotide—SSTR3—brain—conduct disorder	0.048	0.153	CbGeAlD
Octreotide—SSTR1—brain—conduct disorder	0.0379	0.121	CbGeAlD
Octreotide—SSTR2—brain—conduct disorder	0.0322	0.103	CbGeAlD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0208	0.0302	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Other—DRD4—conduct disorder	0.0186	0.0271	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CGA—conduct disorder	0.0158	0.023	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0158	0.0229	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0157	0.0228	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0151	0.022	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—DRD4—conduct disorder	0.0146	0.0213	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0136	0.0198	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0134	0.0195	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0129	0.0187	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0124	0.018	CbGpPWpGaD
Octreotide—MPO—brain—conduct disorder	0.0122	0.0391	CbGeAlD
Octreotide—SSTR2—GPCRs, Other—HTR2A—conduct disorder	0.0121	0.0177	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CGA—conduct disorder	0.012	0.0175	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0118	0.0172	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0116	0.0169	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CGA—conduct disorder	0.0115	0.0167	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—DRD4—conduct disorder	0.0111	0.0161	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—DRD4—conduct disorder	0.0106	0.0155	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0103	0.015	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CGA—conduct disorder	0.0102	0.0148	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00987	0.0144	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00967	0.0141	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00963	0.014	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—DRD4—conduct disorder	0.00944	0.0137	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CGA—conduct disorder	0.00942	0.0137	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CGA—conduct disorder	0.00895	0.013	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00887	0.0129	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—DRD4—conduct disorder	0.00887	0.0129	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00882	0.0128	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00876	0.0127	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—DRD4—conduct disorder	0.00871	0.0127	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00846	0.0123	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CGA—conduct disorder	0.00812	0.0118	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00808	0.0118	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00789	0.0115	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0076	0.011	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0075	0.0109	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00692	0.0101	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CGA—conduct disorder	0.00678	0.00986	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00672	0.00977	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—DRD4—conduct disorder	0.00672	0.00977	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CGA—conduct disorder	0.0065	0.00946	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00644	0.00937	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—DRD4—conduct disorder	0.00644	0.00937	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CGA—conduct disorder	0.00616	0.00896	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CGA—conduct disorder	0.0059	0.00859	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—HTR2A—conduct disorder	0.00578	0.00841	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CGA—conduct disorder	0.00577	0.00839	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00576	0.00837	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00571	0.00831	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—DRD4—conduct disorder	0.00571	0.00831	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00552	0.00803	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CGA—conduct disorder	0.00532	0.00774	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00527	0.00767	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—DRD4—conduct disorder	0.00527	0.00767	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CGA—conduct disorder	0.00524	0.00762	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0051	0.00742	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—DRD4—conduct disorder	0.00501	0.00729	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0049	0.00712	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CGA—conduct disorder	0.00483	0.00703	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CGA—conduct disorder	0.0048	0.00698	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—EP300—conduct disorder	0.00459	0.00668	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—DRD4—conduct disorder	0.00455	0.00662	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00452	0.00657	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—HTR2A—conduct disorder	0.00438	0.00638	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—HTR2A—conduct disorder	0.0042	0.00611	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00418	0.00608	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—WASF1—conduct disorder	0.00385	0.0056	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DRD4—conduct disorder	0.0038	0.00552	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—HTR2A—conduct disorder	0.00373	0.00542	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—DRD4—conduct disorder	0.00364	0.0053	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CGA—conduct disorder	0.00364	0.00529	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CGA—conduct disorder	0.00349	0.00507	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—DRD4—conduct disorder	0.00345	0.00502	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—HTR2A—conduct disorder	0.00344	0.005	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DRD4—conduct disorder	0.00331	0.00481	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—HTR2A—conduct disorder	0.00327	0.00476	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—DRD4—conduct disorder	0.00323	0.0047	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CGA—conduct disorder	0.00309	0.0045	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—DRD4—conduct disorder	0.00298	0.00433	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HTR2A—conduct disorder	0.00297	0.00432	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DRD4—conduct disorder	0.00293	0.00426	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—WASF1—conduct disorder	0.00292	0.00424	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CGA—conduct disorder	0.00285	0.00415	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—WASF1—conduct disorder	0.00279	0.00407	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—DRD4—conduct disorder	0.00271	0.00394	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DRD4—conduct disorder	0.00269	0.00391	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—WASF1—conduct disorder	0.00248	0.00361	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—HTR2A—conduct disorder	0.00248	0.0036	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00238	0.00346	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—WASF1—conduct disorder	0.00229	0.00333	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HTR2A—conduct disorder	0.00225	0.00327	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HTR2A—conduct disorder	0.00216	0.00314	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—HTR2A—conduct disorder	0.00211	0.00306	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DRD4—conduct disorder	0.00204	0.00296	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DRD4—conduct disorder	0.00195	0.00284	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—HTR2A—conduct disorder	0.00194	0.00283	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HTR2A—conduct disorder	0.00191	0.00278	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HTR2A—conduct disorder	0.00177	0.00257	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HTR2A—conduct disorder	0.00175	0.00255	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DRD4—conduct disorder	0.00173	0.00252	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DRD4—conduct disorder	0.0016	0.00233	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—conduct disorder	0.00133	0.00193	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR2A—conduct disorder	0.00127	0.00185	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR2A—conduct disorder	0.00113	0.00164	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2A—conduct disorder	0.00104	0.00152	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EP300—conduct disorder	0.000929	0.00135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EP300—conduct disorder	0.000704	0.00102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EP300—conduct disorder	0.000675	0.000982	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EP300—conduct disorder	0.000599	0.000871	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EP300—conduct disorder	0.000553	0.000804	CbGpPWpGaD
